These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17591138)

  • 1. Myocardial depression associated with pneumococcal septic shock reversed by levosimendan.
    Ramaswamykanive H; Bihari D; Solano TR
    Anaesth Intensive Care; 2007 Jun; 35(3):409-13. PubMed ID: 17591138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paediatric use of levosimendan in septic shock].
    Monteverde E; Neira P; Farías J
    An Pediatr (Barc); 2008 May; 68(5):529-30. PubMed ID: 18448005
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
    Creteur J; Bouckaert Y; Mélot C; Vincent JL
    Intensive Care Med; 2006 May; 32(5):790; author reply 791-2. PubMed ID: 16555067
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial effects of levosimendan in infants with sepsis-associated cardiac dysfunction: report of 2 cases.
    Papoff P; Caresta E; Versacci P; Pinto R; Moretti C; Midulla F
    Pediatr Emerg Care; 2012 Oct; 28(10):1062-5. PubMed ID: 23034494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
    Unverzagt S; Wachsmuth L; Hirsch K; Thiele H; Buerke M; Haerting J; Werdan K; Prondzinsky R
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009669. PubMed ID: 24385385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock.
    Oldner A; Konrad D; Weitzberg E; Rudehill A; Rossi P; Wanecek M
    Crit Care Med; 2001 Nov; 29(11):2185-93. PubMed ID: 11700420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
    Morelli A; De Castro S; Teboul JL; Singer M; Rocco M; Conti G; De Luca L; Di Angelantonio E; Orecchioni A; Pandian NG; Pietropaoli P
    Intensive Care Med; 2005 May; 31(5):638-44. PubMed ID: 15812624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined arginine vasopressin and levosimendan: a promising therapy for septic shock.
    Yang JJ; Wang X; Ji MH; Peng YG
    Crit Care Med; 2011 Apr; 39(4):921-2; author reply 922. PubMed ID: 21613859
    [No Abstract]   [Full Text] [Related]  

  • 9. Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial.
    Meng JB; Hu MH; Lai ZZ; Ji CL; Xu XJ; Zhang G; Tian S
    Med Sci Monit; 2016 May; 22():1486-96. PubMed ID: 27138236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levosimendan and low cardiac output syndrome. Does mortality really decrease? ].
    Alvarez J
    Rev Esp Cardiol; 2008 May; 61(5):454-7. PubMed ID: 18462647
    [No Abstract]   [Full Text] [Related]  

  • 11. Levosimendan.
    Mason P
    Intensive Crit Care Nurs; 2003 Dec; 19(6):370-1. PubMed ID: 14637297
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery.
    Labriola C; Siro-Brigiani M; Carrata F; Santangelo E; Amantea B
    Int J Clin Pharmacol Ther; 2004 Apr; 42(4):204-11. PubMed ID: 15124978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.
    Ferrer-Barba A; Gonzalez-Rivera I; Bautista-Hernandez V
    Curr Vasc Pharmacol; 2016; 14(1):48-57. PubMed ID: 26463985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of Levosimendan in intensive care treatment of myocardial insufficiency].
    Rehberg S; Ertmer C; Van Aken H; Lange M; Bröking K; Morelli A; Westphal M
    Anaesthesist; 2007 Jan; 56(1):30-43. PubMed ID: 17131137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosimendan for the treatment of subarachnoid hemorrhage-related cardiogenic shock.
    Taccone FS; Brasseur A; Vincent JL; De Backer D
    Intensive Care Med; 2013 Aug; 39(8):1497-8. PubMed ID: 23673402
    [No Abstract]   [Full Text] [Related]  

  • 17. [Superiority of levosimendan to dobutamine in postoperative low cardiac output syndrome: is it due to previous beta-blocker treatment?].
    Homs S; González-Costello J
    Rev Esp Cardiol; 2008 Nov; 61(11):1225; author reply 1225-6. PubMed ID: 19000504
    [No Abstract]   [Full Text] [Related]  

  • 18. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of levosimendan in a patient during cardiopulmonary bypass.
    Iriz E; Erer D; Unal Y; Zor H; Ozkose Z; Ozdogan ME
    J Card Surg; 2007; 22(2):153-6. PubMed ID: 17338755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of levosimendan treatment of myocardial stunning and low-output syndrome after cardiac surgery].
    García-González MJ; Domínguez-Rodríguez A
    Rev Esp Cardiol; 2006 Aug; 59(8):851-2. PubMed ID: 16938238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.